Literature DB >> 18692255

Prevalence of dementia subtypes: a 30-year retrospective survey of neuropathological reports.

Hans Brunnström1, Lars Gustafson, Ulla Passant, Elisabet Englund.   

Abstract

We investigated the distribution of neuropathologically defined dementia subtypes among individuals with dementia disorder. The neuropathological reports were studied on all patients (n=524; 55.3% females; median age 80, range 39-102 years) with clinically diagnosed dementia disorder who underwent complete autopsy including neuropathological examination within the Department of Pathology at the University Hospital in Lund, Sweden, during the years 1974-2004. The neuropathological diagnosis was Alzheimer's disease (AD) in 42.0% of the cases, vascular dementia (VaD) in 23.7%, dementia of combined Alzheimer and vascular pathology in 21.6%, and frontotemporal dementia in 4.0% of the patients. The remaining 8.8% of the patients had other dementia disorders, including combinations other than combined Alzheimer and vascular pathology. The registered prevalence of dementia subtypes depends on many variables, including referral habits, clinical and neuropathological judgments and diagnostic traditions, all of these variables potentially changing over time. This, however, does not seem to obscure the delineation of the major dementia subgroups. In this material of 30 years from Lund in the south of Sweden, AD by far dominated among dementia subtypes, while cerebrovascular pathology corresponded with the dementia disorder, either entirely or partly, in almost half of the demented patients.

Entities:  

Mesh:

Year:  2008        PMID: 18692255     DOI: 10.1016/j.archger.2008.06.005

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  34 in total

1.  Traumatic brain injury history is associated with earlier age of onset of frontotemporal dementia.

Authors:  Christian LoBue; Kristin Wilmoth; C Munro Cullum; Heidi C Rossetti; Laura H Lacritz; Linda S Hynan; John Hart; Kyle B Womack
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-09-10       Impact factor: 10.154

2.  Amyloid in dementia associated with familial FTLD: not an innocent bystander.

Authors:  Georges Naasan; Gil D Rabinovici; Pia Ghosh; Jonathan D Elofson; Bruce L Miller; Giovanni Coppola; Anna Karydas; Jamie Fong; David Perry; Suzee E Lee; Jennifer S Yokoyama; William W Seeley; Joel H Kramer; Michael W Weiner; Norbert Schuff; William J Jagust; Lea T Grinberg; Mochtar Pribadi; Zhongan Yang; Renee Sears; Eric Klein; Kevin Wojta; Howard J Rosen
Journal:  Neurocase       Date:  2015-06-04       Impact factor: 0.881

3.  [Molecular imaging in neurological diseases].

Authors:  M Reimold; C la Fougère
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

Review 4.  Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Authors:  Gil D Rabinovici; Bruce L Miller
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 5.  Diagnosis and management of behavioral variant frontotemporal dementia.

Authors:  Peter S Pressman; Bruce L Miller
Journal:  Biol Psychiatry       Date:  2013-11-13       Impact factor: 13.382

Review 6.  Frontotemporal dementia: diagnosis, deficits and management.

Authors:  Nicholas T Bott; Anneliese Radke; Melanie L Stephens; Joel H Kramer
Journal:  Neurodegener Dis Manag       Date:  2014

Review 7.  Obesity and vulnerability of the CNS.

Authors:  Annadora J Bruce-Keller; Jeffrey N Keller; Christopher D Morrison
Journal:  Biochim Biophys Acta       Date:  2008-10-17

8.  Comorbidity in dementia: update of an ongoing autopsy study.

Authors:  Shino Magaki; William H Yong; Negar Khanlou; Spencer Tung; Harry V Vinters
Journal:  J Am Geriatr Soc       Date:  2014-07-15       Impact factor: 5.562

Review 9.  Update on frontotemporal dementia.

Authors:  Zoe Arvanitakis
Journal:  Neurologist       Date:  2010-01       Impact factor: 1.398

10.  Neuropathology-based risk scoring for dementia diagnosis in the elderly.

Authors:  Sebastien Haneuse; Eric Larson; Rod Walker; Thomas Montine; Joshua Sonnen
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.